Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Colorectal Neoplasms 3Neoplasms 2Breast Neoplasms 2Various Advanced Cancer 1Rectal Neoplasms 1Rectal Diseases 1Metastatic Adenocarcinoma of the Pancreas 1Intestinal Neoplasms 1Intestinal Diseases 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Esophageal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Colonic Neoplasms 1Colonic Diseases 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

zolbetuximab 2Oxaliplatin 2Afatinib 2trastuzumab deruxtecan 1tepotinib 1repotrectinib 1pralsetinib 1brigatinib 1Standard of Care 1Pemetrexed 1Leucovorin 1Fluorouracil 1Crizotinib 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Adenocarcinoma × Fluorouracil × Clear all
NCT03504397 2026-05-04

Spotlight

Astellas Pharma Inc

Phase 3 Active not recruiting
565 enrolled 63 charts 1 FDA
Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡